Resmed Q3 revenue rises on product demand

ResMed

30/04/2026 21:17

Corrects first Overview bullet and Key Details table to say Q3 revenue 'slightly beat,' not 'missed,' expectations; corrects revenue figure in KD table to $1.43 billion from $1.4 billion

Overview

U.S. sleep device maker's Q3 revenue rose 11%, slightly beating analyst expectations

Adjusted EPS for Q3 rose 21% and beat analyst expectations

Company returned $262 mln to shareholders via dividends and buybacks

Outlook

Company did not provide specific financial guidance for future quarters or the full year in its press release

Result Drivers

PRODUCT DEMAND - Co said revenue growth was driven by increased demand for sleep devices, masks and accessories

GROSS MARGIN GAINS - Gross margin rose 290 bps, primarily due to component cost improvements and manufacturing and logistics efficiencies, with a small positive impact from product mix and foreign currency

OPERATING EXPENSES - SG&A expenses increased mainly due to VirtuOx acquisition costs, higher employee costs, and investments in marketing and technology

Company press release: ID:nGNX1v7VJT

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Revenue
Slight Beat*
$1.43 bln
$1.42 bln (16 Analysts)
Q3 Adjusted EPS
Beat
$2.86
$2.80 (14 Analysts)
Q3 EPS
$2.74
Q3 Adjusted Gross Margin
62.80%


*Applies to a deviation of less than 1%; not applicable for per-share numbers.

Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 13 "strong buy" or "buy", 8 "hold" and 1 "sell" or "strong sell"

The average consensus recommendation for the advanced medical equipment & technology peer group is "buy"

Wall Street's median 12-month price target for Resmed Inc is $290.00, about 36.8% above its April 29 closing price of $211.93

The stock recently traded at 18 times the next 12-month earnings vs. a P/E of 21 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)